Application Number: 1 R21 Ai094511-01 Principal Investigator Review Group: Zai1 Rb-a (j1) National Institute of Allergy and Infectious Diseases Special Emphasis Panel Microbicide Innovation Program (mip Vi) (r21/r33) Aids -exp. Rev. Meeting
نویسندگان
چکیده
SRG Action: Impact/Priority Score: 30 Human Subjects: 30-Human subjects involved Certified, no SRG concerns Animal Subjects: 30-Vertebrate animals involved no SRG concerns noted Gender: 3A-Only men, scientifically acceptable Minority: 1A-Minorities and non-minorities, scientifically acceptable Children: 1A-Both Children and Adults, scientifically acceptable Clinical Research not NIH-defined Phase III Trial
منابع مشابه
Clues from CROI.
have emerged that allow researchers to analyze the specificity and function of antigenspecific T-cell responses in exquisite detail. One approach that has been popularized recently by researchers at the Vaccine Research Center (VRC), part of the US National Institute of Allergy and Infectious Diseases (NIAID), is using multi-parameter flow cytometry to analyze the ability of antigen-specific T ...
متن کاملAmerican Society of Nephrology Renal Research Report.
In the spring of 2004, the Board of Advisors and the Council of the American Society of Nephrology believed it necessary to conduct a series of research retreats to steer priorities appropriately in an era of limited resources. In this regard, retreats were conducted by five working groups in areas that were identified to require distinct attention: acute renal failure, diabetic nephropathy, hy...
متن کامل1 The role of ferroportin in macrophage - mediated immunity 1 2 3
This work was supported by grants from the NIH to E.E.J (T90 DK070078, T32 ES007155), 29 M.M. (R21 AI068077). B.J.C. (R21 AI06519) and M.W.R (R01 ES014638 and R01 DK064750). 30 A.S. conducted studies as a research fellow at HSPH. We would like to thank Dr. Igor Kramnik 31 from the Department of Immunology and Infectious Diseases at the Harvard School of Public 32 Health for providing the GF...
متن کاملAntibody to Human Immunodeficiency Virus Type 1 (HIV-1) gp160 in Mucosal Specimens of Asymptomatic HIV-1-Infected Volunteers Parenterally Immunized with an Experimental Recombinant HIV-1 IIIB gp160 Vaccine
JOHN S. LAMBERT,* RAPHAEL VISCIDI, MARY CLARE WALKER, BARBARA CLAYMAN, MARCY WINGET, MARK WOLFF, DAVID H. SCHWARTZ, AND THE NIAID-SPONSORED AIDS VACCINE EVALUATION GROUP The Institute of Human Virology, University of Maryland at Baltimore School of Medicine, Baltimore, Maryland 21201; Schools of Hygiene and Public Health and of Medicine, Johns Hopkins University, Baltimore, Maryland 21205; Divi...
متن کاملImproving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial Networks.
OBJECTIVES To evaluate an external quality assurance (EQA) program for the laboratory diagnosis of human papillomavirus (HPV) disease that was established to improve international research capability within the Division of AIDS at the National Institute of Allergy and Infectious Disease-supported Adult AIDS Clinical Trials Group network. METHODS A three-component EQA scheme was devised compri...
متن کامل